The Factor IX Inhibitor test is primarily used to detect inhibitory antibodies against Factor IX in the blood, which is crucial for patients with hemophilia B receiving Factor IX replacement therapy. It helps diagnose, monitor, and manage treatment effectiveness while identifying abnormal immune responses that may reduce blood clotting efficiency